Can I take proton pump inhibitors (PPIs) with thyroid medication, specifically levothyroxine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Taking Proton Pump Inhibitors with Levothyroxine

Proton pump inhibitors (PPIs) can significantly reduce the absorption of levothyroxine tablets, potentially leading to inadequate thyroid hormone levels. If you need both medications, separate their administration by at least 4 hours or consider alternative levothyroxine formulations such as soft gel capsules or liquid forms.

How PPIs Affect Levothyroxine Absorption

PPIs reduce gastric acid secretion, which creates an environment that impairs the dissolution and absorption of standard levothyroxine tablets. According to the FDA drug label for levothyroxine:

  • PPIs are specifically listed among medications that may decrease T4 absorption, potentially resulting in hypothyroidism 1
  • The label recommends monitoring patients appropriately when these medications are used together

Evidence of Interaction

Multiple studies have demonstrated this interaction:

  • A systematic review found that concomitant use of levothyroxine and PPIs showed a significant increase in TSH concentration, indicating reduced effectiveness of levothyroxine therapy 2
  • This interaction appears to be clinically significant in many patients requiring thyroid hormone replacement

Management Strategies

Option 1: Timing Separation

  • Take levothyroxine at least 4 hours before PPIs
  • This timing separation helps minimize the interaction by allowing levothyroxine to be absorbed before the PPI affects gastric pH

Option 2: Alternative Levothyroxine Formulations

If timing separation is not practical or effective, consider alternative formulations:

  • Soft gel capsules: A 2023 study showed that switching from conventional levothyroxine tablets to soft gel capsules at the same dose in patients taking PPIs resulted in significantly decreased TSH and increased thyroid hormone levels, indicating better absorption 3
  • Liquid formulations: These may also provide better absorption in the presence of PPIs 4

Option 3: Dose Adjustment

  • If alternative formulations are not available, your healthcare provider may need to increase your levothyroxine dose to compensate for reduced absorption
  • This requires careful monitoring of thyroid function tests to ensure proper dosing

Monitoring Recommendations

When taking both medications:

  • Monitor TSH levels more frequently after starting, changing, or discontinuing either medication
  • Watch for symptoms of hypothyroidism (fatigue, cold intolerance, weight gain, constipation)
  • Report any changes in symptoms to your healthcare provider promptly

Special Considerations

  • Timing of administration: Levothyroxine is typically taken in the morning on an empty stomach, at least 30-60 minutes before food
  • Consistency: Take medications at the same time each day to maintain stable blood levels
  • Alternative acid reducers: Some evidence suggests H2 receptor antagonists like famotidine may have less impact on levothyroxine absorption than PPIs 5, though results are inconsistent

Common Pitfalls to Avoid

  1. Taking medications together: Never take levothyroxine and PPIs at the same time
  2. Inconsistent timing: Varying the time of day when you take either medication can lead to fluctuating hormone levels
  3. Self-adjusting doses: Never adjust medication doses without consulting your healthcare provider
  4. Assuming stable dosing: Even with established doses, the addition or removal of a PPI requires reassessment of levothyroxine requirements

By following these guidelines, you can minimize the impact of PPIs on your thyroid hormone replacement therapy and maintain proper thyroid function.

References

Research

IN PATIENTS WITH SUBCLINICAL HYPOTHYROIDISM WHILE IN THERAPY WITH TABLET L-T4, THE LIQUID L-T4 FORMULATION IS MORE EFFECTIVE IN RESTORING EUTHYROIDISM.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2017

Research

The effect of famotidine, esomeprazole, and ezetimibe on levothyroxine absorption.

Thyroid : official journal of the American Thyroid Association, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.